WBA Jan 2025 37.500 call
| Previous close | 0.0800 |
| Open | 0.0700 |
| Bid | 0.0500 |
| Ask | 0.0800 |
| Strike | 37.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0700 - 0.0700 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.09k |
Yahoo FinanceWalgreens launches specialty pharmacy unit to compete in new PBM era
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.
BloombergWalgreens Is Opening a New Pharmacy For Cell and Gene Therapies
(Bloomberg) -- Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.Most Read from BloombergMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsZuckerberg Asks for Patience as Meta’s AI Push Spooks InvestorsMeta’s Miss Sparks Fears in Tech With More Earn
Business WireWalgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
DEERFIELD, Ill., April 25, 2024--Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners. The company today introduced Walgreens Specialty Pharmacy, a holistic offering that expands access to care for patients with complex, chronic conditions and enables partnerships that drive profitability for Walgreens’ pharmacy business. The com
